---
title: "Abbott gains as Baird issues new outperform on growth outlook"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291432591.md"
description: "Abbott Laboratories shares rose after Baird initiated coverage with an Outperform rating and a $121 price target. Analyst David Rescott cites stable long-term growth of 6-8% driven by medical devices, despite recent stock declines and the dilutive impact of the Exact Sciences acquisition. The firm expects consistent earnings growth to resume in 2027 as the company overcomes near-term headwinds."
datetime: "2026-07-01T14:31:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291432591.md)
  - [en](https://longbridge.com/en/news/291432591.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291432591.md)
generator: "portal-rs"
---

# Abbott gains as Baird issues new outperform on growth outlook

Shares of Abbott Laboratories (ABT) gained on Wednesday after Baird initiated coverage with an Outperform rating and a $121 price target, citing a stable growth trajectory for the MedTech company driven by a slew of upcoming catalysts. Baird’s bullish view comes at a time when the Illinois-based healthcare giant has lost more than 25% this year, dr...

### Related Stocks

- [EXAS.US](https://longbridge.com/en/quote/EXAS.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)

## Related News & Research

- [Heritage Trust Co Increases Stock Position in Abbott Laboratories $ABT](https://longbridge.com/en/news/297292932.md)
- [Late-breaking data for Abbott’s TactiFlex™ Duo Ablation Catheter reveal positive outcomes for treating complex AFib cases](https://longbridge.com/en/news/297521993.md)
- [Baird Just Upgraded Deere Stock. Here's Why.](https://longbridge.com/en/news/297677018.md)
- [Edmond DE Rothschild Holding S.A. Acquires Shares of 154,431 Abbott Laboratories $ABT](https://longbridge.com/en/news/297417415.md)
- [Xcel Wealth Management LLC Cuts Stock Holdings in Abbott Laboratories $ABT](https://longbridge.com/en/news/296700328.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**